Table 5.
Microenvironment modulation mechanisms by different biomaterials to enhance bone regeneration in different phases
Strategy | Cement | Modification method | Model | Simulated diseases | Mechanism | Refs. |
---|---|---|---|---|---|---|
Reduction of inflammation | CPC | Magnesium | In vitro | Bone substitute implantation | MCPC reduces macrophage M1 polarization to attenuate inflammation | [93] |
MPC | rhBMP2 + cement scaffold | SD rats | Bone substitute implantation | Mg ions reduce inflammation through macrophage regulation to enhance osteogenesis | [182] | |
CS/CC/DCPA | Mg-MOF | In vitro | Non-load-bearing bone defects | Mg-MOF modulates macrophage M1/M2 polarization | [183] | |
CPC | Zinc-doped calcium silicate | New Zealand white rabbits | Distal femoral bone defect | Zn-CS/CPC promoted the recruitment of macrophages and enhanced M2 polarization while inhibiting M1 polarization | [184] | |
CaSO4 bone cement | Sr/Cu-BSG | SD rats/New Zealand white rabbits | Femoral condylar defects | BSG cement reduces M1 macrophage polarization and inflammatory cytokines while promoting M2 phenotype | [188] | |
Promotion of anti-oxidation | CPC | Se | SD rats | Osteoporotic bone defects | Se-CPC upregulates SOD2/GPX1 antioxidant enzymes | [194] |
CPC | Se | SD rats | Osteoporotic bone defects | Se-CPC rescued mitochondrial functions through activation of the GPx1-mediated antioxidant pathway | [195] | |
PMMA | Amino graphene | Rabbits | Failure of the prosthesis | AG exerts antioxidant effects through free radical scavenging | [163] | |
CPC | Fullerenol | In vitro | Bone reconstruction | The antioxidant activity of Ful not only protected cellular viability but also promoted osteogenic differentiation | [197] | |
Bone homeostasis maintenance | PMMA | TBB initiator | In vitro | Local osteolysis at the cement–bone interface | PMMA-TBB enhances polymerization efficiency and reduces monomer toxicity | [203] |
CPC | Solid lipid microparticles + ALN | In vitro | Severe bone turnover inhibition | Solid lipid microparticles deliver alendronate to promote osteogenesis while inhibiting osteoclastogenesis | [204] | |
PMMA | Borosilicate Glass | SD rats/Goats | Tibia defects/Vertebral defect | BSG provides an alkaline microenvironment that spontaneously balanced the activities between osteoclasts and osteoblasts | [206] | |
CPC | PEGs + ALN | SD rats | Osteoporotic bone defects | CPC buffers pH while ALN inhibits osteoclasts and Ca2 + promotes osteoblast differentiation | [43] | |
Prevascularization | CPC | Chitosan + Arg-Gly-Asp (RGD) | In vitro | Large skeletal defects | RGD-modified CPCs promote rapid vascular integration | [212] |
CPC | hPDLSCs + hUVECs | In vitro | Large skeletal defects | hPDLSCs support vessel formation through angiogenic factors while hUVECs enhance osteogenesis via paracrine signaling | [213] | |
β-TCP scaffolds | In vivo bioreactors for prevascularization | SD rats | Tibia bone defect | In-vivo prevascularization in muscle pouch promotes vessel network formation within β-TCP scaffolds | [214] | |
Material-cell interactions | CPC | Calcium silicate + rhBMP-2 | New Zealand rabbits | Femoral defects | Synergistic effects between calcium silicate and rhBMP-2 in promoting osteogenesis | [219] |
CPC | rhBMP2 + BMSC | Nude mice | Oral and maxillofacial defects | rhBMP2 enhances BMSCs proliferation and osteogenic differentiation through sustained release from CPC scaffolds | [220] | |
CPC | chondroitin sulfate + PDA + rhBMP-2 | SD rats | Bone tissue repair | CS enhances rhBMP-2 bioactivity by promoting BMPR expression and binding | [221] |